Education
About Us
Working with TipRanks
Follow Us
HBL- Hadasit Bio-Holdings Ltd. (IL:HDST.M)
:HDST.M
HDST.M Stock Chart & Stats
Day’s Range― - ―
52-Week Range19.00 - 62.00
Previous CloseN/A
Volume75.00K
Average Volume (3M)926.00
Market Cap
3.69M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.10
Next EarningsN/A
EPS EstimateN/A
Last Dividend Ex-Date
Feb 07, 2019Dividend YieldN/A
Share Statistics
EPS (TTM)-0.31
Shares Outstanding11,088,522
10 Day Avg. Volume1,093
30 Day Avg. Volume926
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Hadasit Bio News
PremiumCompany Announcements
Hadasit Bio Mourns the Loss of CFO and Acting CEO
PremiumCompany Announcements
Hadasit Bio Announces Senior Officers’ Status UpdateHDST.M FAQ
What was HBL- Hadasit Bio-Holdings Ltd.’s price range in the past 12 months?
HBL- Hadasit Bio-Holdings Ltd. lowest stock price was 19.00 and its highest was 62.00 in the past 12 months.
What is HBL- Hadasit Bio-Holdings Ltd.’s market cap?
HBL- Hadasit Bio-Holdings Ltd.’s market cap is 3.69M.
When is HBL- Hadasit Bio-Holdings Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were HBL- Hadasit Bio-Holdings Ltd.’s earnings last quarter?
HBL- Hadasit Bio-Holdings Ltd. released its earnings results on Aug 19, 2021. The company reported 221.4 earnings per share for the quarter, beating the consensus estimate of N/A by 221.4.
Is HBL- Hadasit Bio-Holdings Ltd. overvalued?
According to Wall Street analysts HBL- Hadasit Bio-Holdings Ltd.’s price is currently Overvalued.
Does HBL- Hadasit Bio-Holdings Ltd. pay dividends?
HBL- Hadasit Bio-Holdings Ltd. pays a Notavailable dividend of 58.8 which represents an annual dividend yield of N/A. See more information on HBL- Hadasit Bio-Holdings Ltd. dividends here
What is HBL- Hadasit Bio-Holdings Ltd.’s EPS estimate?
HBL- Hadasit Bio-Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does HBL- Hadasit Bio-Holdings Ltd. have?
HBL- Hadasit Bio-Holdings Ltd. has 11,088,522 shares outstanding.
What happened to HBL- Hadasit Bio-Holdings Ltd.’s price movement after its last earnings report?
HBL- Hadasit Bio-Holdings Ltd. reported an EPS of 221.4 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of HBL- Hadasit Bio-Holdings Ltd.?
Currently, no hedge funds are holding shares in IL:HDST.M
Company Description
HBL- Hadasit Bio-Holdings Ltd.
Hadasit Bio-Holdings Ltd operates in the biotechnology industry in Israel. It primarily focuses on the therapeutic areas, including oncology, regenerative medicine, and inflammatory disease. The company offers ProtAb, an immunotherapeutic monoclonal antibody for the treatment of autoimmune inflammatory diseases. Hadasit Bio-Holdings Ltd was founded in 2005 and is based in Jerusalem, Israel.